Genprex, Inc (GNPX)

Etorro trading 970x250
Genprex, Inc (GNPX) Logo

About Genprex, Inc

Genprex, Inc. operates as a clinical-stage gene therapy company that develops therapies for patients with cancer and diabetes. The company’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes. It develops drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The company’s lead product candidate REQORSA (quaratusugene ozeplasmid) for treatment for non-small cell lung cancer (NSCLC) has a multimodal mechanism of action to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis and programmed cell death in cancer cells; modulate immune response against cancer cells; and block mechanisms that create drug resistance. Genprex, Inc. was founded in 2009 and is headquartered in Austin, Texas. Address: Health Discovery Building, Austin, TX, United States, 78712-1885

Genprex, Inc News and around…

Latest news about Genprex, Inc (GNPX) common stock and company :

48 Biggest Movers From Yesterday
14 Jan, 2022 FinancialContent

Gainers Singularity Future Technology Ltd. (NASDAQ: SGLY) shares rose 25.9% to settle at $5.01 on Thursday. MedAvail Holdings, ...

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Accelerate Opening of Acclaim-1 Clinical Trial Sites
10 Jan, 2022 FinancialContent
Genprex to Accelerate Opening of Acclaim-1 Clinical Trial Sites for REQORSA™ Systemic Gene Therapy in Non-Small Cell Lung Cancer
10 Jan, 2022 FinancialContent

Genprex announced a plan to accelerate the opening of clinical trial sites for the Acclaim-1 clinical trial.

Sweihan PV Power Company PJSC -- Moody's assigns Baa1 rating to 881MW Noor Abu Dhabi solar PV project; outlook stable
10 Jan, 2022 Yahoo! Finance

Rating Action: Moody's assigns Baa1 rating to 881MW Noor Abu Dhabi solar PV project; outlook stableGlobal Credit Research - 10 Jan 2022London, 10 January 2022 -- Moody's Investors Service (Moody's) has today assigned a Baa1 rating to the approximately US$728 million fixed rate, senior secured, amortising bonds due 2049 (the Bonds) to be issued by Sweihan PV Power Company PJSC (the Issuer). The outlook is stable.The Issuer is a special purpose vehicle that owns and operates the 881 megawatt (MW ac) Noor Abu Dhabi solar photovoltaic (PV) independent power project (the Project) located near Sweihan in Abu Dhabi (Abu Dhabi, Government of, Aa2 stable).

2022 Could be a Banner Year for Biotech Stocks as per top managers (SPRC, HOTH, NLSP, PSTV, IMMX, GNPX, NRBO)
06 Jan, 2022 FinancialContent
JinkoSolar's Subsidiary Jinko Solar Co., Ltd.'s Updated IPO Prospectus and Indicative IPO Timetable Published by the Shanghai Stock Exchange
06 Jan, 2022 Yahoo! Finance

JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, is in the process of applying for an initial public offering ("IPO") of the Company's principal operating subsidiary, Jinko Solar Co., Ltd. ("Jiangxi Jinko"), on the Shanghai Stock Exchange's Sci-Tech innovation board. Today, Jiangxi Jinko's updated IPO prospectus and indicative IPO timetable was published by the Shanghai Stock Exchange on its

50 Biggest Movers From Yesterday
06 Jan, 2022 FinancialContent

Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares surged 63.7% to settle at $2.21 on Wednesday after the company ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
05 Jan, 2022 FinancialContent

Gainers Lixte Biotech Holdings (NASDAQ:LIXT) stock increased by 70.4% to $2.3 during Wednesday's regular session. ...

34 Stocks Moving In Wednesday's Mid-Day Session
05 Jan, 2022 FinancialContent

Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 49.7% to $15.45 after the company announced it acquired exclusive rights ...

Genprex to Participate in January Investor and Healthcare Conferences to Highlight Company’s Gene Therapies in Cancer and Diabetes
05 Jan, 2022 FinancialContent

Genprex announces its conference participation for January 2022.

45 Biggest Movers From Yesterday
05 Jan, 2022 FinancialContent

Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged ...

12 Health Care Stocks Moving In Tuesday's Intraday Session
04 Jan, 2022 FinancialContent

Gainers Hoth Therapeutics (NASDAQ:HOTH) shares increased by 97.3% to $1.39 during Tuesday's regular session. As of ...

Genprex's (GNPX) Lead Cancer Drug Gets Second Fast Track Tag
04 Jan, 2022 Yahoo! Finance

The FDA bestows a Fast Track designation to Genprex's (GNPX) Reqorsa in combination with Keytruda for treating patients with non-small cell lung cancer. This is the second Fast Track tag for Reqorsa.

34 Stocks Moving In Tuesday's Mid-Day Session
04 Jan, 2022 FinancialContent

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of ...

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Expands Oncology R&D Pipeline to Include Small Cell Lung Cancer
04 Jan, 2022 FinancialContent
Genprex Expands Gene Therapy Oncology Pipeline to Include Small Cell Lung Cancer
04 Jan, 2022 FinancialContent

Genprex expands its clinical development pipeline to include Small Cell Lung Cancer.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
04 Jan, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! It's time to kick off another day with a dive into the biggest pre-market stock movers for Tuesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

61 Biggest Movers From Yesterday
04 Jan, 2022 FinancialContent

Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for ...

12 Health Care Stocks Moving In Monday's After-Market Session
03 Jan, 2022 FinancialContent

Gainers Indaptus Therapeutics (NASDAQ:INDP) stock rose 6.6% to $6.58 during Monday's after-market session. Today's trading volume for ...

Genprex stock more than doubles on very heavy volume after FTD granted for cancer treatment
03 Jan, 2022 Yahoo! Finance

Shares of Genprex Inc. skyrocketed 121% on massive volume in afternoon trading Monday, after the gene therapy company said its Reqorsa Immunogene Therapy was granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration for use in combination with Merck & Co. Inc.'s cancer treatment Keytruda. Trading volume exploded to 163.9 million shares, compared with the full-day average of about 476,600 shares, and enough to make the stock the most actively traded on major U.S. exchanges. Th

12 Health Care Stocks Moving In Monday's Intraday Session
03 Jan, 2022 FinancialContent

Gainers Genprex (NASDAQ:GNPX) stock moved upwards by 117.5% to $2.85 during Monday's regular session. Genprex's ...

CCL Stock: Why Carnival Is Cruising Higher Despite the CDC’s Covid Call
03 Jan, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Carnival (CCL) stock is heading higher on Monday despite recent concerns about the Covid-19 Omicron variant and CDC warnings. The post CCL Stock: Why Carnival Is Cruising Higher Despite the CDC’s Covid Call appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

TSM Stock: What Investors Are Saying About the Taiwan Semiconductor Breakout Today
03 Jan, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Taiwan Semiconductor (TSM) stock is getting a nice boost today alongside heavy trading even without any news surrounding the company today. The post TSM Stock: What Investors Are Saying About the Taiwan Semiconductor Breakout Today appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

Dow Flat as Tesla Lifts Tech, Autos
03 Jan, 2022 FinancialContent

The Dow Jones Industrial Average is flat midday, as it cools off from this morning's burst higher. Both the S&P 500 Index and Nasdaq Composite are more comfortably in the black.

GNPX Stock: 5 Things to Know as Genprex Rockets Higher
03 Jan, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of GNPX stock are soaring higher after the FDA granted fast track designation (FTD) for the company's lead drug candidate, REQORSA. The post GNPX Stock: 5 Things to Know as Genprex Rockets Higher appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, GNPX, AFI, CELZ, AUVI, WAVE
03 Jan, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're diving into the top penny stocks to watch today as several names in the space see major movement on Monday alongside heavy trading. The post 8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, GNPX, AFI, CELZ, AUVI, WAVE appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

Why Genprex Shares Are Soaring Today
03 Jan, 2022 FinancialContent

Genprex Inc (NASDAQ: GNPX) is trading higher Monday afterthe company announced it received U.S. Food and Drug ...

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Granted Fast Track Designation for Proprietary Immunogene Therapy from FDA
03 Jan, 2022 FinancialContent
Genprex's Lead Cancer Program Scores Second FDA Fast Track Tag For Lung Cancer Setting
03 Jan, 2022 FinancialContent

The FDA hasgranted Fast Track DesignationforGenprex Inc's(NASDAQ: GNPX) lead drug candidate, Reqorsa ...

12 Health Care Stocks Moving In Monday's Pre-Market Session
03 Jan, 2022 FinancialContent

Gainers Immix Biopharma (NASDAQ:IMMX) shares increased by 61.5% to $5.75 during Monday's pre-market session. The ...

Genprex, Inc (GNPX) is a NASDAQ Common Stock listed in , ,

970x250